Clinical Trials Browser

Phase 1/2 × Urinary Bladder Neoplasms × Cystectomy × Clear all

NCT06957561 2025-05-04

DIVON

Phase 1/2 Not yet recruiting

Urinary Bladder Neoplasms

NCT06341400 2024-12-04

RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients

Phase 1/2 Recruiting

Urinary Bladder Neoplasms

NCT02845050 2018-02-13

JaNEO

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms